On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to...
05.07.2017
- Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...
03.03.2017
- Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
08.11.2016
- Cancer Research UK is aligning with the Wellcome Trust and investment groups Syncona and BACIT to create a new company with assets of up to £1 billion that will invest in life...
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
10.07.2013
- British pharmaceutical company AstraZeneca has agreed its first research partnerships in Cambridge for cancer treatments ahead of its relocation to the university city by 2016. The...
16.05.2012
- Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new...
